×

Our award-winning reporting has moved

Context provides news and analysis on three of the world’s most critical issues:

climate change, the impact of technology on society, and inclusive economies.

Uganda to deploy Ebola vaccine if virus spreads from Congo

by Reuters
Thursday, 20 September 2018 16:58 GMT

A Congolese health worker prepares to administer Ebola vaccine, outside the house of a victim who died from Ebola in the village of Mangina in North Kivu province of the Democratic Republic of Congo, August 18, 2018. REUTERS/Olivia Acland

Image Caption and Rights Information

Uganda borders Congo's Ituri and North Kivu provinces, where Ebola is believed to have killed 97 people since the July outbreak

DAKAR, Sept 20 (Reuters) - Uganda will vaccinate against Ebola should it spread from Democratic Republic of Congo, which has been hit twice this year, the World Health Organization (WHO) said on Thursday.

Uganda borders Congo's Ituri and North Kivu provinces, where Ebola is believed to have killed 97 people since the latest outbreak started in July, and infected another 45.

A death from Ebola was recorded this month in the Congolese city of Butembo , which is a hub for Congolese mineral exports and imports from East African ports via Uganda.

In a statement on Thursday, the WHO said it was assisting Uganda, which has remained clear of Ebola so far this year, to set up the "ring vaccination" strategy being used in Congo.

Under the strategy, every contact of an Ebola case including health workers and family members is traced and vaccinated.

"The opportunity that vaccinating frontline health workers and ring vaccination provides to contain the disease (...) is one that must never be missed. That's why we are making all these costly but necessary preparations", WHO's Uganda Representative Yonas Tegegn Woldermariam said in the statement.

Uganda has identified spaces to store the vaccine and installed equipment to ensure it can be transported nationwide.

Uganda has had five outbreaks since 2000, the latest in 2017. The contagious disease causes hemorrhagic fever, vomiting and diarrhea. Ebola killed 11,300 in West Africa in 2013-2016, though treatment during that outbreak was less advanced.

The experimental vaccine, manufactured by Merck, was first deployed to the Congo this year. It is designed to target the Zaire strain of the virus, which was confirmed to have caused Congo's current outbreak.

(Reporting by Tom Miles in Geneva Writing by Sofia Christensen)

Our Standards: The Thomson Reuters Trust Principles.

-->